| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/14/2001 | WO2001042270A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001042269A1 Human cysteinyl leukotriene receptor |
| 06/14/2001 | WO2001042268A1 Dog orexin 1 receptor |
| 06/14/2001 | WO2001042267A1 Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001042266A1 Antisense modulation of amyloid beta protein expression |
| 06/14/2001 | WO2001041815A2 Metastasis genes and uses thereof |
| 06/14/2001 | WO2001041805A1 Novel cdna 22360 associated with renal disease and other disease states |
| 06/14/2001 | WO2001041801A2 Mutant simplex virus for treating unwanted hyperproliferative cell growth |
| 06/14/2001 | WO2001041799A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041791A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 06/14/2001 | WO2001041788A1 INDUCING CELLULAR IMMUNE RESPONSES TO p53 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 06/14/2001 | WO2001041787A1 INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 06/14/2001 | WO2001041786A1 METHODS TO STIMULATE INSULIN PRODUCTION BY PANCREATIC β-CELLS |
| 06/14/2001 | WO2001041741A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 06/14/2001 | WO2001041556A1 Method of using mapk4 and orthologues thereof to control plant disease resistance and plant growth |
| 06/14/2001 | WO2001030811A3 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 06/14/2001 | WO2001027244A9 Body member with adjustable stiffness and frequency |
| 06/14/2001 | WO2001025253A3 Temperature-sensitive regulation of viral vector production |
| 06/14/2001 | WO2001023561A3 Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats |
| 06/14/2001 | WO2001018041A3 Flint proteins and formulations thereof |
| 06/14/2001 | WO2001018036A3 Methods and reagents for regulating gene expression |
| 06/14/2001 | WO2001016168A3 Induction of programmed cell death by n5 gene |
| 06/14/2001 | WO2001009337A3 Moraxella catarrhalis antigens basb122 and basb124 |
| 06/14/2001 | WO2001009189A3 Compositions and methods for the treatment of tumors |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | WO2001000829A8 Human endogenous retrovirus in breast cancer |
| 06/14/2001 | WO2000068267A9 LOW-DOSE IL-1β-INDUCED PHOTORECEPTOR CELL RESCUE WITHOUT RETINAL DYSPLASIA |
| 06/14/2001 | WO2000035950A9 Reagents and methods useful for detecting diseases of the breast |
| 06/14/2001 | WO2000032631A3 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/14/2001 | WO1998037194A9 Ell2, a member of an ell family of rna polymerase ii elongation factors |
| 06/14/2001 | WO1998031818A9 Tace-like and matrilysin-like polypeptides |
| 06/14/2001 | US20010003848 For the preparation of transgenic crop plants, such as tobacco, potatoes, beets and maize with increased yield, by altering their nitrogen metabolism |
| 06/14/2001 | US20010003739 Systemic administration of a therapeutic preparation |
| 06/14/2001 | US20010003650 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries |
| 06/14/2001 | CA2396739A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/14/2001 | CA2395417A1 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 06/14/2001 | CA2394970A1 Novel steroid-activated nuclear receptors and uses therefor |
| 06/14/2001 | CA2394921A1 Supracolonic aerodigestive neoplasm detection |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2394303A1 Interferon-alpha induced gene |
| 06/14/2001 | CA2393960A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393859A1 Apoptin-associating protein |
| 06/14/2001 | CA2393763A1 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 06/14/2001 | CA2393738A1 Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393730A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 06/14/2001 | CA2393662A1 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393659A1 Multimeric forms of tnf superfamily ligands |
| 06/14/2001 | CA2393644A1 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | CA2393589A1 Compositions and methods for detecting stress-inducible proteins |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393463A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 06/14/2001 | CA2393447A1 Novel human membrane proteins and polynucleotides encoding the same |
| 06/14/2001 | CA2393433A1 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| 06/14/2001 | CA2393339A1 Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393084A1 Immunoassay for neonicotinyl insecticides |
| 06/14/2001 | CA2393045A1 Mutant er.alpha. and test systems for transactivation |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392764A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 06/14/2001 | CA2392753A1 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 06/14/2001 | CA2392742A1 T1 receptor-like ligand ii and uses thereof |
| 06/14/2001 | CA2392740A1 Il-6 like polynucleotides, polypeptides, and antibodies |
| 06/14/2001 | CA2392299A1 Methods for expression of genes in primates |
| 06/14/2001 | CA2392268A1 Production of peptides by fedbatch cultivation of a microorganism |
| 06/14/2001 | CA2390687A1 Metastasis genes and uses thereof |
| 06/14/2001 | CA2390093A1 Extracellular matrix and cell adhesion molecules |
| 06/14/2001 | CA2383001A1 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | CA2382165A1 Full-length human cdnas encoding potentially secreted proteins |
| 06/14/2001 | CA2362685A1 Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens |
| 06/13/2001 | EP1106697A1 Mass secretion/expression system of true mk family protein |
| 06/13/2001 | EP1106693A1 Nucleotide sequence encoding the zwa2 protein |
| 06/13/2001 | EP1106691A1 Apoptin-associating protein |
| 06/13/2001 | EP1106690A2 Polynucleotide encoding autoantigens associated with endometriosis |
| 06/13/2001 | EP1106689A2 Nucleic acids encoding acetylcholine beta subunits from insects |
| 06/13/2001 | EP1106688A1 Genes for detecting bacteria and detection method by using the same |
| 06/13/2001 | EP1106686A1 Artiodactyl epimorphine |
| 06/13/2001 | EP1106623A1 Method for purifying FSH |
| 06/13/2001 | EP1106060A1 Model animal with visualized nerve network |
| 06/13/2001 | EP1105738A1 Assays, methods and means for modulating nuclear localisation |
| 06/13/2001 | EP1105734A2 Homer interacting proteins |
| 06/13/2001 | EP1105733A1 Receptor for underivatized, aqueous soluble beta-(1,3)-glucan |
| 06/13/2001 | EP1105731A2 Profiling and cataloging expressed protein tags |
| 06/13/2001 | EP1105526A1 Hepg2 cells stably transfected with hcv |
| 06/13/2001 | EP1105525A1 A process for preparing peptide nucleic acid probe using polymeric photoacid generator |
| 06/13/2001 | EP1105518A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 06/13/2001 | EP1105516A1 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| 06/13/2001 | EP1105513A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 06/13/2001 | EP1105511A1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors |
| 06/13/2001 | EP1105508A1 Method for purifying proteins and biomolecule or protein complexes |
| 06/13/2001 | EP1105507A1 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression |
| 06/13/2001 | EP1105506A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 06/13/2001 | EP1105505A2 Compound and method for the prevention and/or the treatment of allergy |
| 06/13/2001 | EP1105503A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1) |
| 06/13/2001 | EP1105501A2 Tpl-2/cot kinase and methods of use |
| 06/13/2001 | EP1105498A1 Hiv vaccine |
| 06/13/2001 | EP1105497A1 Cold-adapted equine influenza viruses |
| 06/13/2001 | EP1105496A1 Modified hcv peptide vaccines |
| 06/13/2001 | EP1105495A2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 06/13/2001 | EP1105494A2 Drug targets in candida albicans |